IEyeNews

iLocal News Archives

The Editor Speaks: Multiple sclerosis

The MS Foundation of the Cayman Islands are inviting all Multiple Sclerosis (MS) patients and their families to meet Dr. Romnesh de Souza on Oct. 18th at 6 p.m.

Dr. de Souza is a consultant in the Neurology Department at Health City Cayman Islands.

Please see our story published last Tuesday 10 “Multiple sclerosis patients in Cayman Islands invited to meet Dr. Romnesh de Souza” at: http://www.ieyenews.com/wordpress/multiple-sclerosis-patients-in-cayman-islands-invited-to-meet-dr-romnesh-de-souza/

MS is an illness close to my wife, Joan, as one of her sons is suffering badly from it.

Before Dr. de Souza’s arrival, there was no physician in Cayman who had specialized in multiple sclerosis.

THE CAUSE OF MS IS UNKNOWN.

THERE IS NO CURE FOR MS.

What is MS?

From Mayo Clinic:

Multiple sclerosis signs and symptoms may differ greatly from person to person and over the course of the disease depending on the location of affected nerve fibers. They may include:

Numbness or weakness in one or more limbs that typically occurs on one side of your body at a time, or the legs and trunk
Partial or complete loss of vision, usually in one eye at a time, often with pain during eye movement
Prolonged double vision
Tingling or pain in parts of your body
Electric-shock sensations that occur with certain neck movements, especially bending the neck forward (Lhermitte sign)
Tremor, lack of coordination or unsteady gait
Slurred speech
Fatigue
Dizziness
Problems with bowel and bladder function

When to see a doctor

See a doctor if you experience any of the above symptoms for unknown reasons.
Disease course

Most people with MS have a relapsing-remitting disease course. They experience periods of new symptoms or relapses that develop over days or weeks and usually improve partially or completely. These relapses are followed by quiet periods of disease remission that can last months or even years.

Small increases in body temperature can temporarily worsen signs and symptoms of MS, but these aren’t considered disease relapses.

About 60 to 70 percent of people with relapsing-remitting MS eventually develop a steady progression of symptoms, with or without periods of remission, known as secondary-progressive MS.

The worsening of symptoms usually includes problems with mobility and gait. The rate of disease progression varies greatly among people with secondary-progressive MS.

Some people with MS experience a gradual onset and steady progression of signs and symptoms without any relapses. This is known as primary-progressive MS.

The cause of multiple sclerosis is unknown. It’s considered an autoimmune disease in which the body’s immune system attacks its own tissues. In the case of MS, this immune system malfunction destroys myelin (the fatty substance that coats and protects nerve fibers in the brain and spinal cord).

Myelin can be compared to the insulation coating on electrical wires. When the protective myelin is damaged and nerve fiber is exposed, the messages that travel along that nerve may be slowed or blocked. The nerve may also become damaged itself.

It isn’t clear why MS develops in some people and not others. A combination of genetics and environmental factors appears to be responsible.

These factors may increase your risk of developing multiple sclerosis:

Age. MS can occur at any age, but most commonly affects people between the ages of 15 and 60.
Sex. Women are about twice as likely as men are to develop MS.
Family history. If one of your parents or siblings has had MS, you are at higher risk of developing the disease.
Certain infections. A variety of viruses have been linked to MS, including Epstein-Barr, the virus that causes infectious mononucleosis.
Race. White people, particularly those of Northern European decent, are at highest risk of developing MS. People of Asian, African or Native American descent have the lowest risk.
Climate. MS is far more common in countries with temperate climates, including Canada, the northern United States, New Zealand, southeastern Australia and Europe.
Certain autoimmune diseases. You have a slightly higher risk of developing MS if you have thyroid disease, type 1 diabetes or inflammatory bowel disease.
Smoking. Smokers who experience an initial event of symptoms that may signal MS are more likely than nonsmokers to develop a second event that confirms relapsing-remitting MS.

People with multiple sclerosis also may develop:

Muscle stiffness or spasms
Paralysis, typically in the legs
Problems with bladder, bowel or sexual function
Mental changes, such as forgetfulness or mood swings
Depression
Epilepsy

SOURCE: https://www.mayoclinic.org/diseases-conditions/multiple-sclerosis/symptoms-causes/dxc-20131884

Sadly, Joan’s son is well in the secondary stage of this awful disease.

If there is no cure for MS you might feel going to see Dr. de Souza is a waste of time. It is not. Especially if MS is in early stages.

There are many treatments that include physical therapy that can slow down its progression and managing the symptoms.

The deadline to apply to attend Dr. de Souza’s meeting is Friday, Oct. 13th. All MS sufferers and family members

urge you all to make an appointment by signing up at https://www.facebook.com/msfcayman/photos/a.1753718248177641.1073741829.1660156597533807/1963278643888266/?type=3&theater to find out the venue location and additional information.

2 COMMENTS

  1. I stopped all the Multiple sclerosis medicines prescribed due to severe side effects, and decided to go on natural herbal approach. My primary care provider introduced me to Rich Herbs Foundation and i immediately started on their Multiple Sclerosis herbal formula treatment, this herbal treatment has made a tremendous difference for me. My symptoms including shaking, muscle weakness, fatigue, mood swings, numbness, double vision and urinary retention all disappeared after the 4 months treatment! Their page is w w w. r i c h h e r b s f o u n d a t i o n. c o m. Its just amazing!

LEAVE A RESPONSE

Your email address will not be published. Required fields are marked *